ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Cara Therapeutics Inc

Cara Therapeutics Inc (CARA)

0.91
0.041
(4.72%)
Closed March 29 04:00PM
0.91
0.00
(0.00%)
After Hours: 05:31PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.91
Bid
0.872
Ask
0.93
Volume
637,279
0.85 Day's Range 0.96
0.50 52 Week Range 5.20
Market Cap
Previous Close
0.869
Open
0.853
Last Trade
2
@
0.9289
Last Trade Time
Financial Volume
$ 577,275
VWAP
0.905844
Average Volume (3m)
728,337
Shares Outstanding
54,656,413
Dividend Yield
-
PE Ratio
-0.57
Earnings Per Share (EPS)
-1.56
Revenue
41.87M
Net Profit
-85.47M

About Cara Therapeutics Inc

Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, an... Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Cara Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CARA. The last closing price for Cara Therapeutics was $0.87. Over the last year, Cara Therapeutics shares have traded in a share price range of $ 0.50 to $ 5.20.

Cara Therapeutics currently has 54,656,413 shares outstanding. The market capitalization of Cara Therapeutics is $48.64 million. Cara Therapeutics has a price to earnings ratio (PE ratio) of -0.57.

CARA Latest News

Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024

STAMFORD, Conn., March 07, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of...

Form S-8 - Securities to be offered to employees in employee benefit plans

  As filed with the Securities and Exchange Commission on March 6, 2024 Registration No. 333-     UNITED STATES SECURITIES AND EXCHANGE...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 8-K - Current report

false 0001346830 0001346830 2024-03-04 2024-03-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED...

Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results

–Announced prioritization of clinical programs to focus on late-stage development of oral difelikefalin for notalgia paresthetica (NP)– –Completed enrollment of KOURAGE 1 Part A portion of NP...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549     SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.011.111111111110.90.960.7234339820.81689421CS
40.022.247191011240.891.150.7237316410.91184119CS
120.229933.80385237470.68011.150.57283370.75846323CS
26-0.78-46.15384615381.691.740.57239940.88430113CS
52-4.13-81.94444444445.045.20.58853452.2578911CS
156-19.13-95.459081836320.0429.64730.58000659.5384566CS
260-17.93-95.1698513818.8429.64730.570703412.37484106CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 22.08
(364.84%)
31.9M
NXLNexalin Technologies Inc
$ 1.50
(92.31%)
11.67M
CEROCERo Therapeutics Holdings Inc
$ 3.112
(90.92%)
24.08M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
KYCHKeyarch Acquisition Corporation
$ 12.30
(75.58%)
196.62k
BOLDBoundless Bio Inc
 14.25
(-76.24%)
767.63k
PMECPrimech Holdings Ltd
$ 1.2999
(-66.50%)
8.28M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.1816
(-44.45%)
21.92M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
NBSTWNewbury Street Acquisition Corporation
$ 0.042279
(-38.28%)
1.75k
NKLANikola Corporation
$ 1.035
(13.85%)
163.84M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
MARAMarathon Digital Holdings Inc
$ 22.56
(2.22%)
86.14M
AKANAkanda Corporation
$ 0.1166
(-29.29%)
80.34M

CARA Discussion

View Posts
glenn1919 glenn1919 3 weeks ago
CARA.....................................................https://stockcharts.com/h-sc/ui?s=CARA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 1 month ago
CARA..............................https://stockcharts.com/h-sc/ui?s=CARA&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 2 months ago
CARA new 52 week low
👍️0
Monksdream Monksdream 6 months ago
CARA under $2
👍️0
WallStreetMyWay WallStreetMyWay 2 years ago
Yeah, good entry room for upwards momentum?
👍️0
WallStreetMyWay WallStreetMyWay 2 years ago
Moving up saved its nice growing money nows is timing?
👍️0
a surfer a surfer 2 years ago
Got some bounce today.
👍️0
BottomBounce BottomBounce 2 years ago
https://www.benzinga.com/news/earnings/21/11/24060763/you-ask-we-analyze-why-sundial-growers-stock-could-slam-short-sellers $CARA
👍️0
conix conix 2 years ago
CARA chart

👍️0
Jake L Jake L 2 years ago
CARA - Update

👍️0
Jake L Jake L 2 years ago
CARA - Friday Rundown, Monday Expectations

👍️0
estreet7883 estreet7883 2 years ago
This chart is looking GREAT!!!
👍️0
Jake L Jake L 2 years ago
CARA - On The Run Again

👍️0
Jake L Jake L 2 years ago
CARA - Friday Rundown, Monday Expectations

👍️0
Jake L Jake L 2 years ago
CARA - Update

👍️0
Jake L Jake L 2 years ago
CARA - Wednesday Rundown, Thursday Expectations

👍️0
Jake L Jake L 2 years ago
CARA - Friday Rundown, Monday Expectations

👍️0
Jake L Jake L 2 years ago
CARA - Monday Rundown, Tuesday Expectations

👍️0
Jake L Jake L 3 years ago
CARA - Tuesday Rundown, Wednesday Expectations

👍️0
Jake L Jake L 3 years ago
CARA - Monday Rundown, Tuesday Expectations

👍️0
Jake L Jake L 3 years ago
CARA - Major Buy Alert

👍️0
Jake L Jake L 3 years ago
CARA - SHOULD HAVE IN YOUR WATCH LIST

👍️0
Jake L Jake L 3 years ago
CARA - Friday Rundown

👍️0
Jake L Jake L 3 years ago
CARA - Update Morning Report

👍️0
MikeKato2002 MikeKato2002 3 years ago
Correct! I rode this one back in 2016 betting that some day they would get FDA approval for a marketable product. Now we have that marketable product and a good chunk of money to fund the pipeline for the next product. Meanwhile the stock trades at a historically deep discount to where it was without FDA approval.

I'm back in at $14.50 for the first time since 2016. Free money.

Good Luck!

04/20/2016 08:26:57 Bought 1200 CARA @ 8.98

-10,785.95 9.95 0.00

04/20/2016 08:26:57 Bought 300 CARA @ 8.97

-2,691.00 0.00 0.00

04/20/2016 09:51:48 Bought 500 CARA @ 8.51

-4,264.95 9.95 0.00

04/29/2016 12:04:51 Bought 1000 CARA @ 6.05

-6,059.95 9.95 0.00

11/16/2016 18:23:35 Sold 2500 CARA @ 12.24

30,589.38 9.95 0.67

11/18/2016 20:22:06 Sold 500 CARA @ 12.0202

6,000.02 9.95 0.13
👍️0
Chefboy69 Chefboy69 3 years ago
LONG here, i knew this would recover AFTER the sell on news event. And its up on lower volume LOL. This is a $30-$40 long term stock. IT will take a few months but it will get there.

This is no pump and i don't ever post in here. Just wanted to post and now i am out..see ya

and good luck all
👍️0
Jake L Jake L 3 years ago
CARA - Wednesday Rundown, Thursday Expectations

👍️0
MikeKato2002 MikeKato2002 3 years ago
Item 8.01 Other Information.


As previously disclosed, on August 23, 2021, Cara Therapeutics, Inc. (“Cara”) received approval of its New Drug Application for KORSUVA™ injection for the treatment of moderate-to-severe pruritus in hemodialysis patients from the U.S. Food and Drug Administration (the “Approval Milestone”). Pursuant to a securities purchase agreement (the “Purchase Agreement”) between Cara and Vifor (International) Ltd. (“Vifor Pharma”), dated October 15, 2020, Cara is eligible to receive $50 million common stock investment at a 20% premium to the 30-day trailing average price of Cara’s common stock ending on the date immediately prior to the achievement of the Approval Milestone. A description of the Purchase Agreement is included in Cara’s Current Report on Form 8-K filed with the Securities and Exchange Commission (“SEC”) on October 20, 2020 and is incorporated herein by reference.



In connection with the achievement of the Approval Milestone on August 23, 2021, Cara will receive from Vifor Pharma a $50.0 million investment in Cara’s common stock at a price of $15.23 per share, equaling 3,282,391 shares of Cara’s common stock (the “Milestone Investment”). The closing of the Milestone Investment will occur within five business days following the expiration of the requisite waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976.



This Current Report on Form 8-K is not an offer to sell or the solicitation of an offer to buy shares of shares of common stock or other securities of Cara.





http://archive.fast-edgar.com/20210831/ABBO422D8C22N2Z2222H2CZZBCASZ2U2D232/tm2126615d1_8k.htm


👍️0
Jake L Jake L 3 years ago
CARA - Tuesday Rundown, Wednesday Expectations

👍️0
Jake L Jake L 3 years ago
CARA - Monday Morning Report

👍️0
Jake L Jake L 3 years ago
CARA - Monday's Plays Which will Short Squeeze

👍️0
Jake L Jake L 3 years ago
CARA - 1K To 100K Challenge Update

👍️0
Jake L Jake L 3 years ago
CARA - Friday Rundown, Monday Expectations

👍️0
Jake L Jake L 3 years ago
CARA - Thursday Rundown, Friday Expectations

👍️0
Jake L Jake L 3 years ago
CARA - Update 1k to 100k Challenge

👍️0
TheFinalCD TheFinalCD 3 years ago
CARA down amc up


this market is upside down
👍️0
Jake L Jake L 3 years ago
CARA - Tuesday Rundown, Wednesday Expectations

👍️0
Jake L Jake L 3 years ago
CARA - Don't Panic

👍️0
saigai saigai 3 years ago
well im out as well. and i know a lost a few here...grrrrrr
👍️0
TheFinalCD TheFinalCD 3 years ago
back to 14.60's SMH!!! I sold rest @15+



have to wait to tomorrow to see the net profit/loss

I think I lost a few sheckles on CARA

will check in the am




Sell 3,000 Shares Limit $15.03 Expires on 10/25/2021 1:12 PM 08/24/2021
Sold 500 $15.03 Settles 08/26/2021 1:12 PM 08/24/2021
Sold 100 $15.03 Settles 08/26/2021 1:12 PM 08/24/2021
Sold 100 $15.03 Settles 08/26/2021 1:12 PM 08/24/2021
Canceled 2,300 blank 1:12 PM 08/24/2021
CLOSEDPartial FillCost Basis Method*: View/Edit Order #: 55194959
Resubmit
Sell 2,300 Shares Limit $15.00 Expires on 10/25/2021 1:12 PM 08/24/2021
Sold 2,300 $15.0001 Settles 08/26/2021 1:12 PM 08/24/2021
CLOSEDFilled
👍️0
saigai saigai 3 years ago
only holding 700 got rid of a flip for a few pennies but im not giving up on this ticker yet..i dont want to walk away from this one losing...but i will if i have to
👍️0
TheFinalCD TheFinalCD 3 years ago
sold most around even after adding lower

still have 2500 shares left


#LETS SEE



Sell 4,000 Shares Limit $15.21 Expires on 10/25/2021 12:43 PM 08/24/2021
Sold 2,950 $15.21 Settles 08/26/2021 12:43 PM 08/24/2021
Sold 1,050 $15.21 Settles 08/26/2021 12:43 PM 08/24/2021
CLOSEDFilledCost Basis Method*: View/Edit Order #: 55147402
Sell 4,000 Shares Limit or Better $15.22 Expires on 10/25/2021 12:44 PM 08/24/2021
Sold 500 $15.235 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 500 $15.235 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 300 $15.235 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 200 $15.232 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 1,000 $15.235 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 100 $15.23 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 669 $15.2301 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 100 $15.2301 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 100 $15.2301 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 200 $15.231 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 100 $15.2301 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 100 $15.2301 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 131 $15.2301 Settles 08/26/2021 12:44 PM 08/24/202
👍️0
TheFinalCD TheFinalCD 3 years ago
I was out @ 17.96, feel like a stooge going back in

giving up profits and going red :/

whats also crazy is todays VWAP is only 15.22

thats low considering 31M volume on 50m os


https://finviz.com/quote.ashx?t=cara


👍️0
TheFinalCD TheFinalCD 3 years ago
SOOOOOOOOOOOOOOOO G00D
👍️0
saigai saigai 3 years ago
what bugs me the most is that this was a trade and i blew it and my long positions are having a good day and this stinking trade teals from those good decisions.. up overall but i hate myself when i kill a good decision with a greedy chase
👍️0
TheFinalCD TheFinalCD 3 years ago
SA article 200% Upside Possible

https://seekingalpha.com/article/4448087-cara-therapeutics-200-percent-upside-possible


WAIT theres more...
https://www.tipranks.com/news/article/cara-therapeutics-could-climb-on-korsuva-drugs-success?utm_source=advfn.com&utm_medium=referral
👍️0
stock1ace1 stock1ace1 3 years ago
yah id say shorts crushed it as usual
👍️0
TheFinalCD TheFinalCD 3 years ago
high fructose corn syrup
👍️0
stock1ace1 stock1ace1 3 years ago
what happend ?
👍️0
saigai saigai 3 years ago
👍️0

Your Recent History

Delayed Upgrade Clock